Published

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: JAMA psychiatry
Date: 2022-10-01
Source: PubMed
DOI: 10.1001/jamapsychiatry.2022.2096
PubMed: 36001306

Authors

Bogenschutz MP Ross S Bhatt S Baron T Forcehimes AA Laska E Mennenga SE O'Donnell K Owens LT Podrebarac S Rotrosen J Tonigan JS Worth L

Watch author

Derived topics and classifications

psilocybin Addiction Clinical Trial Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks2026-08-17 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12 Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex2026-07-28 Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions2026-07-03 Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study2026-07-01 Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits2026-07-01 Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”2026-06-30 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex2026-06-01 Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache2026-05-29 Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder2026-05-26 Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15 Psilocybin in the Treatment of Cocaine Use Disorder2026-05-07 Human brain changes after first psilocybin use2026-05-05 Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms2026-05-01 Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression2026-05-01 Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics2026-04-30 Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey2026-04-15 Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01